# INTS6

## Overview
INTS6, or integrator complex subunit 6, is a gene that encodes a protein integral to the function of the integrator complex, a multi-protein assembly involved in RNA processing and transcription regulation. The INTS6 protein is characterized by the presence of a conserved Von Willebrand factor type A (VWA) domain, which facilitates protein-protein interactions, particularly within the integrator complex (Fujiwara2023IntS6). Functionally, INTS6 is involved in the termination of transcription at small nuclear RNA (snRNA) and replication-dependent histone mRNA loci, as well as in DNA repair and cell cycle regulation, underscoring its role in maintaining genomic stability and cellular integrity (Skaar2015The; MendozaFigueroa2020The). Clinically, INTS6 has been implicated in various cancers, acting as a tumor suppressor in some contexts, such as prostate and hepatocellular carcinoma, while exhibiting oncogenic properties in others, like colorectal cancer (Peng2015Pseudogene; Filleur2009INTS6DICE1; Ding2021INTS6).

## Structure
The INTS6 protein, a component of the integrator complex, is involved in RNA processing and transcription termination. It contains a conserved Von Willebrand factor type A (VWA) domain at its N-terminus, which is known to facilitate protein-protein interactions (Fujiwara2023IntS6). The Drosophila homolog of INTS6 is composed of 1,284 amino acids, suggesting a similar size for the human protein, although specific details on the human protein's primary structure are not provided (Fujiwara2023IntS6).

INTS6 interacts with protein phosphatase 2A (PP2A) subunits, indicating a role in modulating phosphatase activity within the integrator complex. This interaction suggests that INTS6 may function similarly to a PP2A regulatory B subunit, affecting transcription termination efficiency at specific gene loci (Fujiwara2023IntS6). The protein's interaction with PP2A subunits is crucial for its role in transcription regulation, as over-expression of INTS6 can titrate PP2A activity, impacting gene expression (Fujiwara2023IntS6).

The molecular structure of INTS6, including its secondary, tertiary, and quaternary structures, is not detailed in the available context. However, its functional interactions within the integrator complex highlight its importance in RNA processing and transcription regulation.

## Function
INTS6, also known as integrator complex subunit 6, is a component of the Integrator complex, which is involved in the regulation of transcription and RNA processing in human cells. It plays a crucial role in the termination of transcription at small nuclear RNA (snRNA) and replication-dependent histone mRNA loci by interacting with RNA Polymerase II (Pol II) and other components of the Integrator complex (Skaar2015The). INTS6 is also implicated in the regulation of protein-coding gene expression, where it modulates transcription termination events and affects the expression of certain genes (Fujiwara2023IntS6).

In addition to its role in transcription regulation, INTS6 is involved in DNA repair processes. It relocates to sites of DNA damage and facilitates the accumulation of repair proteins, contributing to genomic stability (MendozaFigueroa2020The). INTS6 is also associated with cell cycle regulation, particularly in the context of tumor suppression, where its re-expression in certain cancer cell lines can lead to cell cycle arrest (Filleur2009INTS6DICE1).

INTS6 is active in the nucleus, where it contributes to various cellular processes, including transcription regulation, DNA repair, and cell cycle control, highlighting its importance in maintaining cellular and genomic integrity.

## Clinical Significance
INTS6, also known as integrator complex subunit 6, has been implicated in various cancers due to its role in tumor suppression and cell cycle regulation. In prostate cancer, INTS6 is frequently down-regulated due to allelic deletion and promoter hypermethylation, leading to decreased mRNA levels in cancerous tissues compared to normal prostate tissue. Re-expression of INTS6 in prostate cancer cell lines has been shown to suppress colony formation by inducing G1 cell cycle arrest, highlighting its tumor suppressive function (Filleur2009INTS6DICE1).

In contrast, INTS6 appears to have an oncogenic role in colorectal cancer (CRC), where its expression is significantly increased in cancerous tissues. This upregulation is associated with poor prognosis and enhanced cell proliferation through the activation of the PI3K/AKT and MAPK/ERK signaling pathways. Downregulation of INTS6 in CRC leads to G1/S-phase cell cycle arrest and reduced tumor growth, suggesting its potential as a therapeutic target (Ding2021INTS6).

In hepatocellular carcinoma (HCC), INTS6 acts as a tumor suppressor. It is down-regulated in HCC tissues, and its expression is regulated by miR-17-5p. The pseudogene INTS6P1 also plays a role in this regulatory network, acting as a sponge for miR-17-5p, thereby influencing INTS6 expression and function (Peng2015Pseudogene).

## Interactions
INTS6, also known as integrator complex subunit 6, is involved in several protein-protein interactions within the integrator complex. It interacts with the protein phosphatase 2A (PP2A) subunits, affecting the phosphatase module of the integrator complex. This interaction suggests that INTS6 may titrate PP2A subunits away from the integrator complex, thereby influencing its phosphatase activity (Fujiwara2023IntS6). INTS6 also interacts with the SOSS1 (NABP2) complex and is suspected to have a direct protein-protein interaction with INTS3 (Fianu2024Reconstitution).

The interaction between INTS3 and INTS6 is crucial for DNA double-strand break (DSB) repair. The INTS3/INTS6 complex enhances the binding of the SOSS1 complex to longer single-stranded DNA (ssDNA), which is important for the DNA damage response (Jia2021Crystal). The crystal structure of the INTS3c/INTS6c complex reveals that INTS3 dimerization is necessary for this interaction, forming a 2:1 molar ratio with INTS6 (Jia2021Crystal). Specific residues in INTS6 are critical for its binding to INTS3, and mutations in these residues can disrupt their interaction, affecting INTS6's nuclear localization (Jia2021Crystal).


## References


1. (Fianu2024Reconstitution) Reconstitution of the Integrator complex and its interaction with paused transcription elongation complex of Pol II-DSIF-NELF. This article has 0 citations.

[2. (Skaar2015The) Jeffrey R Skaar, Andrea L Ferris, Xiaolin Wu, Anita Saraf, Kum Kum Khanna, Laurence Florens, Michael P Washburn, Stephen H Hughes, and Michele Pagano. The integrator complex controls the termination of transcription at diverse classes of gene targets. Cell Research, 25(3):288–305, February 2015. URL: http://dx.doi.org/10.1038/cr.2015.19, doi:10.1038/cr.2015.19. This article has 125 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2015.19)

[3. (MendozaFigueroa2020The) María Saraí Mendoza-Figueroa, Deirdre C. Tatomer, and Jeremy E. Wilusz. The integrator complex in transcription and development. Trends in Biochemical Sciences, 45(11):923–934, November 2020. URL: http://dx.doi.org/10.1016/j.tibs.2020.07.004, doi:10.1016/j.tibs.2020.07.004. This article has 43 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tibs.2020.07.004)

[4. (Filleur2009INTS6DICE1) Stephanie Filleur, Jennifer Hirsch, Aline Wille, Margarete Schön, Christian Sell, Michael H Shearer, Thomas Nelius, and Ilse Wieland. Ints6/dice1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and wnt signaling. Cancer Cell International, 9(1):28, 2009. URL: http://dx.doi.org/10.1186/1475-2867-9-28, doi:10.1186/1475-2867-9-28. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1475-2867-9-28)

[5. (Fujiwara2023IntS6) Rina Fujiwara, Si-Nan Zhai, Dongming Liang, Aayushi P. Shah, Matthew Tracey, Xu-Kai Ma, Christopher J. Fields, María Saraí Mendoza-Figueroa, Michele C. Meline, Deirdre C. Tatomer, Li Yang, and Jeremy E. Wilusz. Ints6 and the integrator phosphatase module tune the efficiency of select premature transcription termination events. Molecular Cell, 83(24):4445-4460.e7, December 2023. URL: http://dx.doi.org/10.1016/j.molcel.2023.10.035, doi:10.1016/j.molcel.2023.10.035. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2023.10.035)

[6. (Jia2021Crystal) Yu Jia, Zixiu Cheng, Sakshibeedu R. Bharath, Qiangzu Sun, Nannan Su, Jun Huang, and Haiwei Song. Crystal structure of the ints3/ints6 complex reveals the functional importance of ints3 dimerization in dsb repair. Cell Discovery, August 2021. URL: http://dx.doi.org/10.1038/s41421-021-00283-0, doi:10.1038/s41421-021-00283-0. This article has 13 citations.](https://doi.org/10.1038/s41421-021-00283-0)

[7. (Peng2015Pseudogene) Haoran Peng, Masaharu Ishida, Ling Li, Atsushi Saito, Atsushi Kamiya, James P. Hamilton, Rongdang Fu, Alexandru V. Olaru, Fangmei An, Irinel Popescu, Razvan Iacob, Simona Dima, Sorin T. Alexandrescu, Razvan Grigorie, Anca Nastase, Ioana Berindan-Neagoe, Ciprian Tomuleasa, Florin Graur, Florin Zaharia, Michael S. Torbenson, Esteban Mezey, Minqiang Lu, and Florin M. Selaru. Pseudogene ints6p1 regulates its cognate gene ints6 through competitive binding of mir-17-5p in hepatocellular carcinoma. Oncotarget, 6(8):5666–5677, January 2015. URL: http://dx.doi.org/10.18632/oncotarget.3290, doi:10.18632/oncotarget.3290. This article has 48 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.3290)

[8. (Ding2021INTS6) Xufen Ding, Tianwei Chen, Qian Shi, Peng Nan, Xiang Wang, Dong Xie, and Jingjing Li. Ints6 promotes colorectal cancer progression by activating of akt and erk signaling. Experimental Cell Research, 407(2):112826, October 2021. URL: http://dx.doi.org/10.1016/j.yexcr.2021.112826, doi:10.1016/j.yexcr.2021.112826. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2021.112826)